Is breast cancer in young Asian women more aggressive than in Caucasians? A cross-sectional analysis

Tumor Biology

Volumn 34, Issue 4, 2013, Pages 2379-2382

  Tea, Muy Kheng M ^a,b   Fan, Lei ^a   Delancey, James W ^c   Staudigl, Christine ^b   Steurer, Stefan ^b,d   Lang, Christina ^b   Shao, Zhi Ming ^a   Singer, Christian F ^b  

^a FUDAN UNIVERSITY   (China)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Department of Health Systems Management ^*  (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Asian breast cancer; Biological characteristics; Breast cancer in the young; China; Ethnic differences

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; ASIAN; AUSTRIA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CAUCASIAN; CHINA; CHINESE; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 84881474549     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0786-z     Document Type: Article

References (22)

1. Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308-24.
2. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358(3):213-6.
3. Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, et al. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat. 2009;117(2):409-16.
4. Hankey BF, Miller B, Curtis R, Kosary C. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr. 1994;16:7-14.
5. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36(3):237-49.
6. Calle EE, Martin LM, Thun MJ, Miracle HL, Heath Jr CW. Family history, age, and risk of fatal breast cancer. Am J Epidemiol. 1993;138(9):675-81.
7. Lee CG, McCormick B, Mazumdar M, Vetto J, Borgen PI. Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumors. Int J Radiat Oncol Biol Phys. 1992;23(5):969-75.
8. Walker RA, Lees E, Webb MB, Dearing SJ. Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer. 1996;74(11):1796-800.
9. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324-30.
10. Xiong Q, Valero V, Kau V, Kau SW, Taylor S, Smith TL, et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer. 2001;92(10):2523-8.
11. Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Cancer. 2008;112(4):737-47.
12. Yang H, Wang SY, Ou W, Sun HB, Fang Q. Clinical characteristics and prognosis of very young patients with breast cancer in the southern of China. Chin J Cancer. 2009;28(12):1310-6.
13. Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. Spectrum of breast cancer in Asian women. World J Surg. 2007;31(5):1031-40.
14. Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999;230(5):692-6.
15. Koscielny S, Arriagada R, Adolfsson J, Fornander T, Bergh J. Impact of tumour size on axillary involvement and distant dissemination in breast cancer. Br J Cancer. 2009;101(6):902-7.
16. Comen EA, Norton L, Massague J. Breast cancer tumor size, nodal status, and prognosis: biology trumps anatomy. J Clin Oncol. 2011;29(19):2610-2.
17. Gao JD, Wang J, Feng XL, Zhong YX. Wang X: [Characterization of hormone receptor status in 5758 Chinese females with breast cancer]. Zhonghua Zhong Liu Za Zhi. 2009;31(9):683-6.
18. Chow LW, Ho P. Hormonal receptor determination of 1,052 Chinese breast cancers. J Surg Oncol. 2000;75(3):172-5.
19. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118-45.
20. Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, Lichtensztajn D, et al. Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat. 2011;127(2):471-8.
21. Cheng HT, Huang T, Wang W, Yue JQ, Shen N, Guo H, et al. Clinicopathological features of breast cancer with different molecular subtypes in Chinese women. J Huazhong Univ Sci Technol Med Sci. 2013;33(1):117-21.
22. Liu JJ, Zhang S, Hao X, Xie J, Zhao J, Wang J, et al. Breast-conserving therapy versus modified radical mastectomy: Socioeconomic status determines who receives what-Results from case-control study in Tianjin, China. Cancer Epidemiol. 2012;36(1):89-93.